Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial is a research paper published in UNC Libraries (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01AI152703-02
Modeling the HIV latent reservoir, latency reversal and immunotherapeutics for HIV cure
National Institutes of Health
Grant: 1U54HL143541-01
The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
National Institutes of Health
Grant: 3UM1AI068636-14S2
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
National Institutes of Health
Grant: 5UM1AI068634-09
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
National Institutes of Health
Grant: 5R01AI028433-25
Immune System Modeling/HIV
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
Grant: 5R01AI116868-05
Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords
Sustainable Development Goals